1. Home
  2. Directory
  3. North Dakota
  4. West Fargo
  5. Optometrist
  6. NPI Profile
  7. Prescriptions 1114239282

BROOKE MARIE MESSER O.D.
Prescription History 1114239282
Optometrist in West Fargo, ND


Quality Rating: 76.29 out of 100 score

NPI Status: Active since July 06, 2010

Contact Information

354 23RD AVE E
WEST FARGO, ND
ZIP 58078
Phone: (701) 566-5390
Fax: (605) 371-7199

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for BROOKE MARIE MESSER O.D., an active Optometrist specialist practicing in West Fargo, ND. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 128 documented patient claims. Among these therapy options, the most frequently utilized medication is Prednisolone Acetate, which accounts for 44 claims alone.

Medication Index

C
D
L
M
P
No matching medications currently found on file.

Combigan

Generic Formulation: Brimonidine Tartrate/TimololSpecialty: Optometry
Provider Metrics Summary
Total Claims 14
30-Day Fills 26.6
Days Supply 788
ND State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills49.2
Peer Average Days Supply1,352
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.0% less volume than the regional standard for practitioners inside ND. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,775.56 across this reporting matrix range.

Provider Avg Cost Per Claim

$269.68

State Avg Cost Per Claim

$315.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.

Therapeutic Applications

This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details.

Difluprednate

Generic Formulation: DifluprednateSpecialty: Optometry
Provider Metrics Summary
Total Claims 21
30-Day Fills 23.3
Days Supply 538
ND State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills27.3
Peer Average Days Supply605
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across ND. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,494.79 across this reporting matrix range.

Provider Avg Cost Per Claim

$166.42

State Avg Cost Per Claim

$138.92

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat swelling and pain after eye surgery. It may also be used to treat a certain serious eye problem (endogenous anterior uveitis). This medication belongs to a class of drugs known as corticosteroids.

Latanoprost

Generic Formulation: LatanoprostSpecialty: Optometry
Provider Metrics Summary
Total Claims 15
30-Day Fills 25.1
Days Supply 699
ND State Average Benchmarks
Peer Average Claims108.0
Peer Average 30-Day Fills165.7
Peer Average Days Supply4,549
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 86.1% less volume than the regional standard for practitioners inside ND. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $233.91 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.59

State Avg Cost Per Claim

$16.28

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.

Therapeutic Applications

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.

Moxifloxacin

Generic Formulation: Moxifloxacin HclSpecialty: Optometry
Provider Metrics Summary
Total Claims 34
30-Day Fills 34.0
Days Supply 430
ND State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills42.9
Peer Average Days Supply663
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across ND. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,045.36 across this reporting matrix range.

Provider Avg Cost Per Claim

$30.75

State Avg Cost Per Claim

$34.90

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent.

Therapeutic Applications

This medication is a quinolone antibiotic used for eye infections.

Prednisolone Acetate

Generic Formulation: Prednisolone AcetateSpecialty: Optometry
Provider Metrics Summary
Total Claims 44
30-Day Fills 65.2
Days Supply 1,737
ND State Average Benchmarks
Peer Average Claims74.0
Peer Average 30-Day Fills102.1
Peer Average Days Supply2,705
Conservative Utilization

This provider writes prescriptions for this formulation 40.5% less frequently than the standard regional baseline metric for practitioners inside ND. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,127.57 across this reporting matrix range.

Provider Avg Cost Per Claim

$48.35

State Avg Cost Per Claim

$59.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain eye conditions due to inflammation or injury. Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like BROOKE MARIE MESSER O.D. provides transparency into local medical care patterns within West Fargo, ND.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Optometrist** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.